JAMA Publishes HRT Study JAMA. 2008;299(9):1036-1045. Context: The Women's Health Initiative (WHI) trial of estrogen plus progestin vs placebo was stopped early, after a mean 5.6 years of follow-up, because the overall health risks of hormone therapy exceeded its … [Read more...] about Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
Archives for March 4, 2008
Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
The Women's Health Initiative (WHI) Trial Team Gerardo Heiss, MD; Robert Wallace, MD; Garnet L. Anderson, PhD; Aaron Aragaki, MS; Shirley A. A. Beresford, PhD; Robert Brzyski, MD; Rowan T. Chlebowski, MD; Margery Gass, MD; Andrea LaCroix, PhD; JoAnn E. Manson, MD; Ross L. … [Read more...] about Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin